Tevogen Bio (TVGN) News Today $1.30 +0.12 (+9.83%) As of 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Tevogen initiated with a Buy at D. Boral CapitalMarch 4 at 11:29 AM | markets.businessinsider.comD. Boral Capital Initiates Coverage on Tevogen Bio (NASDAQ:TVGN)D. Boral Capital began coverage on shares of Tevogen Bio in a report on Tuesday. They issued a "buy" rating and a $10.00 price objective on the stock.March 4 at 8:18 AM | marketbeat.comTevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient OperationsMarch 3 at 12:52 PM | globenewswire.comTevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Down 47.5% in FebruaryTevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) saw a large decline in short interest in February. As of February 15th, there was short interest totalling 1,460,000 shares, a decline of 47.5% from the January 31st total of 2,780,000 shares. Currently, 5.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 2,750,000 shares, the short-interest ratio is currently 0.5 days.March 2 at 8:07 AM | marketbeat.comTevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell TherapyFebruary 28, 2025 | globenewswire.comTevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-OwnedFebruary 21, 2025 | markets.businessinsider.comTevogen Bio's First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-OwnedFebruary 21, 2025 | globenewswire.comTevogen Bio CEO reinforces commitment to retention of equity capitalFebruary 17, 2025 | msn.comTevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term VisionFebruary 14, 2025 | globenewswire.comTevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and ProsperityFebruary 14, 2025 | markets.businessinsider.comTevogen CEO addresses broader implications of short-sellingFebruary 14, 2025 | markets.businessinsider.comTevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational EfficiencyFebruary 14, 2025 | globenewswire.comTevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation's Health and ProsperityFebruary 14, 2025 | globenewswire.comTevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for AmericansFebruary 13, 2025 | globenewswire.comTevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest UpdateTevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,780,000 shares, an increase of 127.9% from the January 15th total of 1,220,000 shares. Based on an average daily trading volume, of 3,280,000 shares, the days-to-cover ratio is currently 0.8 days. Approximately 11.2% of the shares of the stock are short sold.February 13, 2025 | marketbeat.comTevogen Bio Holdings Inc. (TVGN) Engages BARDA on AI-Driven ExacTcell Immunotherapy AdvancementsFebruary 11, 2025 | insidermonkey.comTevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient InnovationFebruary 10, 2025 | globenewswire.comTevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical CountermeasureFebruary 8, 2025 | finance.yahoo.comTevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology's Potential as a Scalable Medical CountermeasureFebruary 7, 2025 | globenewswire.comTevogen Bio Inc: Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant FundingFebruary 1, 2025 | finanznachrichten.deTevogen Bio Holdings Inc. (TVGN): Accelerating Precision Medicine with Microsoft AI CollaborationJanuary 29, 2025 | insidermonkey.comTevogen Bio (NASDAQ:TVGN) Shares Down 8.9% - Time to Sell?Tevogen Bio (NASDAQ:TVGN) Trading Down 8.9% - Time to Sell?January 29, 2025 | marketbeat.comTevogen receives initial $2M grant, may receive $8M more at future dateJanuary 28, 2025 | markets.businessinsider.comTevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant FundingJanuary 28, 2025 | finance.yahoo.comTevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant FundingJanuary 28, 2025 | globenewswire.comTevogen Bio Stock Soars on Expanded Team-Up with MicrosoftJanuary 27, 2025 | marketwatch.comTevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority OutreachJanuary 27, 2025 | globenewswire.comTevogen Bio stock surges after expanded AI partnership with MicrosoftJanuary 27, 2025 | seekingalpha.comWhat's Going On With Tevogen Bio Stock Today?January 27, 2025 | benzinga.comTevogen Bio and Microsoft expand AI collaboration to PredicTcell techJanuary 27, 2025 | finance.yahoo.comTevogen Bio Holdings, Inc. (TVGN): Advancing Immunotherapy through AI PartnershipsJanuary 25, 2025 | msn.comTevogen Bio announces AI collaboration with MicrosoftJanuary 25, 2025 | markets.businessinsider.comStocks to Watch: Richardson Electronics, Tevogen Bio HoldingsJanuary 24, 2025 | marketwatch.comTevogen stock rallies on expanded Microsoft AI collaborationJanuary 24, 2025 | msn.comTevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on AzureJanuary 24, 2025 | globenewswire.comTevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare ConferenceJanuary 23, 2025 | globenewswire.comTevogen Bio Holdings Inc. (TVGN): AI Innovations in ImmunotherapyJanuary 17, 2025 | msn.comTevogen Bio Holdings Inc. (NASDAQ:TVGN) Sees Large Decline in Short InterestTevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 1,180,000 shares, a decrease of 21.3% from the November 30th total of 1,500,000 shares. Based on an average trading volume of 16,290,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.5% of the shares of the stock are short sold.December 29, 2024 | marketbeat.comTevogen Bio to Host Panels on AI in Biopharma and Healthcare Economics at 2025 JPM Healthcare ConferenceDecember 28, 2024 | nasdaq.comTevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare ConferenceDecember 26, 2024 | globenewswire.comTevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | globenewswire.comTevogen Bio (TVGN) Advances AI-Driven Immunotherapy with New Patent FilingDecember 20, 2024 | insidermonkey.comTevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth AgendaDecember 19, 2024 | globenewswire.comTevogen Bio Holdings Inc.: Excessive Insider Ownership And Poised For A Seasonal ReboundDecember 18, 2024 | seekingalpha.comTevogen Bio to Host Panel "Pioneering the Economics of Health: Balancing Access and Outcomes" During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | tmcnet.comTevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | globenewswire.comTevogen Bio Claims $10 Billion IP Potential But Hinges On MonetizationDecember 17, 2024 | seekingalpha.comTevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Up 93.6% in NovemberTevogen Bio Holdings Inc. (NASDAQ:TVGN - Get Free Report) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 1,500,000 shares, a growth of 93.6% from the November 15th total of 774,700 shares. Currently, 6.7% of the shares of the stock are short sold. Based on an average trading volume of 16,110,000 shares, the short-interest ratio is currently 0.1 days.December 12, 2024 | marketbeat.comTevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 10, 2024 | globenewswire.comDr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of FameDecember 5, 2024 | globenewswire.com Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address TVGN Media Mentions By Week TVGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TVGN News Sentiment▼0.910.70▲Average Medical News Sentiment TVGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TVGN Articles This Week▼73▲TVGN Articles Average Week Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Rocket Pharmaceuticals News Today Phibro Animal Health News Today Evolus News Today AbCellera Biologics News Today ArriVent BioPharma News Today Oculis News Today Pharvaris News Today Cogent Biosciences News Today Prothena News Today Avid Bioservices News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TVGN) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
